Psychiatry and Neurology, Neurology · Terre Haute, IN
NPI
1881949576
Since 2012
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1739 N 4th St
Terre Haute, IN, 47804
Phone (812) 242-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
5,405 services
Medicare patients, 2024
527
Average age 73
Drug cost, 2024
$4.5M
6,829 prescriptions
Company payments, 2025
$13K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adelle A Maynard - Watts was code 99214 (office e&m - established), 691 times for 453 patients. In total Adelle A Maynard - Watts billed 5,405 services in 19 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 691 | 453 | $85.80 | $59K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 654 | 446 | $11.52 | $7,535 |
| 99215 Office E&M - Established | Office | 110 | 91 | $117.63 | $13K |
| 95819 Neurologic | Facility | 50 | 48 | $32.82 | $1,641 |
| 99204 Office E&M - New | Office | 32 | 32 | $92.64 | $2,964 |
| 99205 Office E&M - New | Office | 18 | 18 | $148.82 | $2,679 |
By year: 2022 $112K for 4,744 services; 2023 $111K for 5,748 services; 2024 $109K for 5,405 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adelle A Maynard - Watts prescribed most often to Medicare patients was Donepezil Hcl, with 350 prescriptions and refills. In total Adelle A Maynard - Watts wrote 6,829 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 350 | 750 | 82 | $3,831 |
| Gabapentin Generic | 328 | 715 | 94 | $6,816 |
| Memantine Hcl Generic | 319 | 706 | 95 | $12K |
| Qulipta Atogepant | 296 | 384 | 42 | $403K |
| Primidone Generic | 280 | 554 | 60 | $9,169 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 274 | 544 | 67 | $6,656 |
| Ubrelvy Ubrogepant | 273 | 341 | 55 | $502K |
| Pregabalin Generic | 267 | 363 | 47 | $11K |
| Levetiracetam Generic | 258 | 584 | 70 | $7,344 |
| Tizanidine Hcl Generic | 230 | 472 | 67 | $2,841 |
| Duloxetine Hcl Generic | 227 | 577 | 56 | $4,648 |
| Nurtec Odt Rimegepant Sulfate | 225 | 233 | 39 | $295K |
| Aimovig Autoinjector Erenumab-Aooe | 187 | 249 | 25 | $186K |
| Amitriptyline Hcl Generic | 186 | 444 | 54 | $3,700 |
| Topiramate Generic | 185 | 459 | 45 | $3,031 |
Brand drugs: 1,717 claims; generic drugs: 5,101 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adelle A Maynard - Watts $13K ($13K in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $12K |
| UCB, Inc. UCB.BR | 2 | $141 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $51.75 |
| MDD US Operations, LLC | 2 | $36.54 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.58 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $29.15 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $26.65 |
| EMD Serono, Inc. MRK.DE | 1 | $24.93 |
| Celgene Corporation BMY | 1 | $23.86 |
| Merz Pharmaceuticals, LLC | 1 | $23.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.